Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-02-02 00:00:00 ET · period of report 2024-02-01 · accession 0001628280-24-003139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-02 | 2024-02-01 | LFCR | Calloway Nathaniel | Dir | M - OptEx | — | +3,981 | 28.1K | +17% | — |
| D | 2024-02-02 | 2024-02-01 | LFCR | Calloway Nathaniel | Dir | M - OptEx | $0.00 | -3,981 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-01 | M | A | 3,981 | — | 28,069 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Derivative | Restricted Stock Unit | 2024-02-01 | M | D | 3,981 | $0.00 | 0 | D | — · 2024-02-01 to — | 3,981 Common Stock | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F2) The restricted stock units vested on February 1, 2024. |